Approval · Notice of Compliance 229 · 2003
HELICIDE: Notice of Compliance 229
Issued March 14, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 229
- Date
- March 14, 2003
- Company
- Axcan Pharma Inc.Mont St-Hilaire, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Helicobacter pylori eradication therapy in conjunction with omeprazole
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HELICIDE | 02246962 | Marketed |
Medicinal ingredients
- METRONIDAZOLE 125 MG per CAP
- TETRACYCLINE HCL 125 MG per CAP
- BISKALCITRATE POTASSIUM 140 MG per CAP